9,500,000 Shares DISCOVERY LABORATORIES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 10th, 2013 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Discovery Laboratories Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Stifel, Nicolaus & Company, Incorporated (the “Underwriter”) an aggregate of 9,500,000 shares (the “Firm Shares”) of the common stock, par value $0.001 per share, of the Company (“Common Stock”). The Company also proposes to sell to the Underwriter, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriter, up to an additional 1,425,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares.”
